| Guidance for the management of patients with vascular disease or cardiovascular risk factors and COVID-19: position paper from VAS-European independent foundation in angiology … GT Gerotziafas, M Catalano, MP Colgan, Z Pecsvarady, JC Wautrecht, ... Thrombosis and haemostasis 120 (12), 1597-1628, 2020 | 190 | 2020 |
| The relationship between fibrinogen to albumin ratio and severity of coronary artery disease in patients with STEMI O Karahan, H Acet, F Ertaş, O Tezcan, A Çalişkan, M Demir, AF Kaya, ... The American Journal of Emergency Medicine 34 (6), 1037-1042, 2016 | 83 | 2016 |
| Reasons, procedures, and outcomes in ventriculoatrial shunts: A single-center experience C Yavuz, S Demırtas, A Calıskan, K Kamasak, O Karahan, O Guclu, ... Surgical neurology international 4, 2013 | 57 | 2013 |
| Antiangiogenic activities of bemiparin sodium, enoxaparin sodium, nadroparin calcium and tinzaparin sodium OT Dogan, ZA Polat, O Karahan, K Epozturk, A Altun, I Akkurt, A Cetin Thrombosis research 128 (4), e29-e32, 2011 | 49 | 2011 |
| Simple blood tests as predictive markers of disease severity and clinical condition in patients with venous insufficiency O Karahan, C Yavuz, N Kankilic, S Demirtas, O Tezcan, A Caliskan, ... Blood Coagulation & Fibrinolysis 27 (6), 684-690, 2016 | 48 | 2016 |
| The relationship between complete blood count parameters and Fontaine’s Stages in patients with peripheral arterial disease S Demirtas, O Karahan, S Yazici, O Guclu, A Caliskan, C Yavuz, ... Vascular 22 (6), 427-431, 2014 | 48 | 2014 |
| Role of CA‐125 in Identification of Right Ventricular Failure in Chronic Obstructive Pulmonary Disease MB Yilmaz, A Zorlu, OT Dogan, O Karahan, I Tandogan, I Akkurt Clinical cardiology 34 (4), 244-248, 2011 | 47 | 2011 |
| Effect of levosimendan in patients with severe systolic heart failure and worsening renal function A Zorlu, H Yücel, OC Yontar, O Karahan, I Tandogan, N Katrancioglu, ... Arquivos Brasileiros de Cardiologia 98, 537-543, 2012 | 36 | 2012 |
| Association of deep venous thrombosis with prothrombotic gene polymorphism identified in lung cancer cases S Arslan, Ş Manduz, K Epöztürk, O Karahan, I Akkurt Molecular biology reports 38, 2395-2400, 2011 | 27 | 2011 |
| Factor-Xa inhibitors protect against systemic oxidant damage induced by peripheral-ischemia reperfusion A Caliskan, C Yavuz, O Karahan, S Yazici, O Guclu, S Demirtas, ... Journal of thrombosis and thrombolysis 37, 464-468, 2014 | 26 | 2014 |
| Repair of Anomalous Origin of the Left Coronary Artery Arising from Right Pulmonary Artery with Rolled‐Conduit‐Extended Reimplantation in an Adult M Erdinc, K Hosgor, O Karahan Journal of Cardiac Surgery 26 (6), 604-607, 2011 | 25 | 2011 |
| The antiangiogenic effects of levosimendan in a CAM assay N Katrancioglu, O Karahan, AT Kilic, A Altun, O Katrancioglu, ZA Polat Microvascular research 83 (3), 263-266, 2012 | 24 | 2012 |
| Investigation of possible prophylactic, renoprotective, and cardioprotective effects of thromboprophylactic drugs against ischemia–reperfusion injury S Demirtas, O Karahan, S Yazıcı, O Guclu, A Calıskan, O Tezcan, I Kaplan, ... The Kaohsiung Journal of Medical Sciences 31 (3), 115-122, 2015 | 23* | 2015 |
| Using oxidant and antioxidant levels to predict the duration of both acute peripheral and mesenteric ischemia S Yazici, S Demirtas, O Guclu, O Karahan, C Yavuz, A Caliskan, ... Perfusion 29 (5), 450-455, 2014 | 23 | 2014 |
| Association between oxidative stress index and serum lipid levels in healthy young adults KA Turkdogan, O Akpinar, M Karabacak, H Akpinar, FT Turkdogan, ... J Pak Med Assoc 64 (4), 379-81, 2014 | 22 | 2014 |
| Rosuvastatin may have neuroprotective effect on spinal cord ischemia reperfusion injury C Yavuz, S Demirtas, O Guclu, O Karahan, A Caliskan, S Yazici, ... CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2013 | 21 | 2013 |
| Analysis of routine blood markers for predicting amputation/re‐amputation risk in diabetic foot A Gülcü, M Etli, O Karahan, A Aslan International Wound Journal 17 (6), 1996-2004, 2020 | 20 | 2020 |
| Investigation of the antiangiogenic behaviors of rivaroxaban and low molecular weight heparins C Yavuz, A Caliskan, O Karahan, S Yazici, O Guclu, S Demirtas, ... Blood Coagulation & Fibrinolysis 25 (4), 303-308, 2014 | 19 | 2014 |
| The role of the CCR2 gene polymorphism in abdominal aortic aneurysms N Katrancioglu, S Manduz, O Karahan, MB Yilmaz, I Sezgin, G Bagci, ... Angiology 62 (2), 140-143, 2011 | 19 | 2011 |
| Comparison of the antiangiogenic effects of heparin sodium, enoxaparin sodium, and tinzaparin sodium by using chorioallantoic membrane assay N Katrancioglu, O Karahan, AT Kilic, A Altun, O Katrancioglu, ZA Polat Blood coagulation & fibrinolysis 23 (3), 218-221, 2012 | 18 | 2012 |
